论文部分内容阅读
本文报告了异可利定对429例消化系疾病解痉止痛的临床研究。总有效率89.5％其中胃肠炎有效率90.2％,消化性溃疡96.6％,胆绞痛87.4％,急性胰腺炎84％和消化道肿瘤87％。用药方法每次肌注异可利定注射液10mg(2ml/安瓿),注后5-20min起效,持续3h以上。副反应仅在少数病例出现轻度口干和面红,未发现肌注阿托品后常有的口渴、瞳孔扩大、心动过速、发热和尿潴留等毒副反应。研究结果表明异可利定是一种适应证较广、疗效高又安全的、新的解痉止痛剂。
This article reports the clinical study of ecotamic and antispasmodic analgesia of 429 cases of digestive diseases. The total effective rate was 89.5%, of which gastroenteritis was 90.2%, peptic ulcer 96.6%, biliary colic 87.4%, acute pancreatitis 84% and gastrointestinal cancer 87%. Medication method Each intramuscular injection of isotretinoin 10mg (2ml / ampoule), note 5-20min onset, sustained 3h above. Side effects in only a few cases of mild dry mouth and face red, and found no intramuscular injection of atropine thirst, dilated pupils, tachycardia, fever and urinary retention and other toxic side effects. The results show that anisil is a widely used indications, high efficacy and safety, a new antispasmodic analgesics.